U.S. Oligonucleotide Synthesis Market Size, Share & Trends Analysis Report By Product & Service (Oligonucleotides, Equipment/Synthesizer), By Application (PCR Primers, Sequencing), By End-use, And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
  • 1.2.1. Product & Service
  • 1.2.2. Application
  • 1.2.3. End-use
• 1.3. Information analysis
• 1.4. Market formulation & data visualization
• 1.5. Data validation & publishing
• 1.6. Information Procurement
  • 1.6.1. Primary Research
• 1.7. Information or Data Analysis
• 1.8. Market Formulation & Validation
• 1.9. Market Model
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Strong pipeline of oligonucleotide therapeutics in clinical trials
    • 3.2.1.2. High R&D spending of pharmaceutical & biotechnology companies
    • 3.2.1.3. Technological advancements in gene editing technologies
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Need for advanced oligo synthesis solutions
    • 3.2.2.2. High cost associated with genomics research
• 3.3. Industry Analysis Tools
  • 3.3.1. Porter's Five Forces Analysis
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. U.S. Oligonucleotide Synthesis Market: Product & Service Business Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. Oligonucleotide Synthesis Market Product & Service Movement Analysis
• 4.3. U.S. Oligonucleotide Synthesis Market Size & Trend Analysis, by Product & Service, 2018 to 2030 (USD Million)
• 4.4. Oligonucleotides
  • 4.4.1. Oligonucleotides market estimates and forecast, 2018 - 2030 (USD Million)
    • 4.4.1.1. DNA
    • 4.4.1.1.1. DNA market estimates and forecast, 2018 - 2030 (USD Million)
    • 4.4.1.1.2. Column-based
    • 4.4.1.1.2.1. Column-based market estimates and forecast, 2018 - 2030 (USD Million)
    • 4.4.1.1.3. Array-based
    • 4.4.1.1.3.1. Array-based market estimates and forecast, 2018 - 2030 (USD Million)
    • 4.4.1.2. RNA
    • 4.4.1.2.1. RNA market estimates and forecast, 2018 - 2030 (USD Million)
    • 4.4.1.2.2. By Technology
    • 4.4.1.2.2.1. Column-based
    • 4.4.1.2.2.1.1. Column-based market estimates and forecast, 2018 - 2030 (USD Million)
    • 4.4.1.2.2.2. Array-based
    • 4.4.1.2.2.2.1. Array-based market estimates and forecast, 2018 - 2030 (USD Million)
    • 4.4.1.2.3. By Type
    • 4.4.1.2.3.1. Short RNA Oligos (<65 nt)
    • 4.4.1.2.3.1.1. Short RNA oligos (<65nt) market estimates and forecast, 2018 - 2030 (USD Million)
    • 4.4.1.2.3.2. Long RNA Oligos (>65 nt)
    • 4.4.1.2.3.2.1. Long RNA oligos (>65 nt) market estimates and forecast, 2018 - 2030 (USD Million)
    • 4.4.1.2.3.3. CRISPR (sgRNA)
    • 4.4.1.2.3.3.1. CRISPR (sgRNA) market estimates and forecast, 2018 - 2030 (USD Million
• 4.5. Equipment/Synthesizer
  • 4.5.1. Equipment/synthesizer market estimates and forecast, 2018 - 2030 (USD Million)
• 4.6. Reagents
  • 4.6.1. Reagents market estimates and forecast, 2018 - 2030 (USD Million)
• 4.7. Services
  • 4.7.1. Services market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.7.2. DNA
    • 4.7.2.1. DNA market estimates and forecast, 2018 - 2030 (USD Million)
    • 4.7.2.2. Custom Oligo Synthesis Services
    • 4.7.2.2.1. 25 nmol
    • 4.7.2.2.1.1. 25 nmol market estimates and forecast, 2018 - 2030 (USD Million)
    • 4.7.2.2.2. 50 nmol
    • 4.7.2.2.2.1. 50 nmol market estimates and forecast, 2018 - 2030 (USD Million)
    • 4.7.2.2.3. 200 nmol
    • 4.7.2.2.3.1. 200 nmol market estimates and forecast, 2018 - 2030 (USD Million)
    • 4.7.2.2.4. 1000 nmol
    • 4.7.2.2.4.1. 1000 nmol market estimates and forecast, 2018 - 2030 (USD Million)
    • 4.7.2.2.5. 10000 nmol
    • 4.7.2.2.5.1. 10000 nmol market estimates and forecast, 2018 - 2030 (USD Million)
    • 4.7.2.3. Modification Services
    • 4.7.2.3.1. Modification services market estimates and forecast, 2018 - 2030 (USD Million)
    • 4.7.2.4. Purification Services
    • 4.7.2.4.1. Purification services market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.7.3. RNA
    • 4.7.3.1. RNA market estimates and forecast, 2018 - 2030 (USD Million)
    • 4.7.3.2. Custom Oligo Synthesis Services
    • 4.7.3.2.1. 25 nmol
    • 4.7.3.2.1.1. 25 nmol market estimates and forecast, 2018 - 2030 (USD Million)
    • 4.7.3.2.2. 100 nmol
    • 4.7.3.2.2.1. 100 nmol market estimates and forecast, 2018 - 2030 (USD Million)
    • 4.7.3.2.3. 1000 nmol
    • 4.7.3.2.3.1. 1000 nmol market estimates and forecast, 2018 - 2030 (USD Million)
    • 4.7.3.2.4. 10000 nmol
    • 4.7.3.2.4.1. 10000 nmol market estimates and forecast, 2018 - 2030 (USD Million)
    • 4.7.3.3. Modification Services
    • 4.7.3.3.1. Modification services market estimates and forecast, 2018 - 2030 (USD Million)
    • 4.7.3.4. Purification Services
    • 4.7.3.4.1. Purification services market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 5. U.S. Oligonucleotide Synthesis Market: Application Business Analysis

• 5.1. Segment Dashboard
• 5.2. U.S. Oligonucleotide Synthesis Market Application Movement Analysis
• 5.3. U.S. Oligonucleotide Synthesis Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 5.4. PCR Primer
  • 5.4.1. PCR primer market estimates and forecast, 2018 - 2030 (USD Million)
• 5.5. PCR Assay & Panel
  • 5.5.1. PCR assay & panel market estimates and forecast, 2018 - 2030 (USD Million)
• 5.6. Sequencing
  • 5.6.1. Sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• 5.7. DNA Microarrays
  • 5.7.1. DNA microarrays market estimates and forecast, 2018 - 2030 (USD Million)
• 5.8. Fluorescence In Situ Hybridization (FISH)
  • 5.8.1. Fluorescence in situ hybridization (FISH) market estimates and forecast, 2018 - 2030 (USD Million)
• 5.9. Antisense Oligonucleotides
  • 5.9.1. Antisense oligonucleotides market estimates and forecast, 2018 - 2030 (USD Million)
• 5.10. Other Applications
  • 5.10.1. Other applications market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6. U.S. Oligonucleotide Synthesis Market: End-use Business Analysis

• 6.1. Segment Dashboard
• 6.2. U.S. Oligonucleotide Synthesis Market End-use Movement Analysis
• 6.3. U.S. Oligonucleotide Synthesis Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
• 6.4. Academic Research Institutes
  • 6.4.1. Academic research institutes market estimates and forecast, 2018 - 2030 (USD Million)
• 6.5. Diagnostic Laboratories
  • 6.5.1. Diagnostic laboratories market estimates and forecast, 2018 - 2030 (USD Million)
• 6.6. Pharmaceutical & Biotechnology Companies
  • 6.6.1. Pharmaceutical & biotechnology companies market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Participant Categorization
• 7.2. Strategy Mapping
• 7.3. Company Market Position Analysis, 2023
• 7.4. Participant's Overview
  • 7.4.1. Thermo Fisher Scientific, Inc.
    • 7.4.1.1. Overview
    • 7.4.1.2. Financial performance
    • 7.4.1.3. Product & service benchmarking
    • 7.4.1.4. Strategic initiatives
  • 7.4.2. Merck KGaA
    • 7.4.2.1. Overview
    • 7.4.2.2. Financial performance
    • 7.4.2.3. Product & service benchmarking
    • 7.4.2.4. Strategic initiatives
  • 7.4.3. Danaher Corporation
    • 7.4.3.1. Overview
    • 7.4.3.2. Financial performance
    • 7.4.3.3. Product & service benchmarking
    • 7.4.3.4. Strategic initiatives
  • 7.4.4. Dharmacon Inc.
    • 7.4.4.1. Overview
    • 7.4.4.2. Financial performance
    • 7.4.4.3. Product & service benchmarking
    • 7.4.4.4. Strategic initiatives
  • 7.4.5. Agilent Technologies
    • 7.4.5.1. Overview
    • 7.4.5.2. Financial performance
    • 7.4.5.3. Product & service benchmarking
    • 7.4.5.4. Strategic initiatives
  • 7.4.6. Bio-synthesis
    • 7.4.6.1. Overview
    • 7.4.6.2. Financial performance
    • 7.4.6.3. Product & service benchmarking
    • 7.4.6.4. Strategic initiatives
  • 7.4.7. LGC Biosearch Technologies
    • 7.4.7.1. Overview
    • 7.4.7.2. Financial performance
    • 7.4.7.3. Product & service benchmarking
    • 7.4.7.4. Strategic initiatives
  • 7.4.8. Twist Bioscience
    • 7.4.8.1. Overview
    • 7.4.8.2. Financial performance
    • 7.4.8.3. Product & service benchmarking
    • 7.4.8.4. Strategic initiatives
  • 7.4.9. TriLink BioTechnologies
    • 7.4.9.1. Overview
    • 7.4.9.2. Financial performance
    • 7.4.9.3. Product & service benchmarking
    • 7.4.9.4. Strategic initiatives
  • 7.4.10. Genscript
    • 7.4.10.1. Overview
    • 7.4.10.2. Financial performance
    • 7.4.10.3. Product & service benchmarking
    • 7.4.10.4. Strategic initiatives

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviations
• Table 3 U.S. oligonucleotide synthesis market, by product & service, 2018 - 2030 (USD Million)
• Table 4 U.S. oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
• Table 5 U.S. oligonucleotide synthesis market, by end-use, 2018 - 2030 (USD Million)
• Table 6 Participant's overview
• Table 7 Financial performance
• Table 8 Key companies undergoing expansions
• Table 9 Key companies undergoing acquisitions
• Table 10 Key companies undergoing collaborations
• Table 11 Key companies launching new products/services
• Table 12 Key companies undertaking other strategies

List of Figures

• Fig. 1 U.S. oligonucleotide synthesis market segmentation
• Fig. 2 Market research process
• Fig. 3 Data triangulation techniques
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 Market outlook
• Fig. 10 Segment snapshot
• Fig. 11 Competitive landscape snapshot
• Fig. 12 Parent market outlook
• Fig. 13 U.S. oligonucleotide synthesis market driver analysis
• Fig. 14 U.S. oligonucleotide synthesis market restraint analysis
• Fig. 15 U.S. oligonucleotide synthesis market: Porter's analysis
• Fig. 16 U.S. oligonucleotide synthesis market: Product & service outlook key takeaways
• Fig. 17 U.S. oligonucleotide synthesis market: Product & service movement analysis
• Fig. 18 Oligonucleotides market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 19 DNA market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 20 Column-based market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 21 Array-based market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 22 RNA market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 23 Column-based market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 24 Array-based market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 25 Short RNA oligos (<65 nt) market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 26 Long RNA oligos (>65 nt) market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 27 CRISPR (sgRNA) market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 28 Equipment/synthesizer market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 29 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 30 Services market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 31 DNA market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 32 Custom oligo synthesis services market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 33 25 nmol market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 34 50 nmol market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 35 200 nmol market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 36 1000 nmol market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 37 10000 nmol market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 38 Modification services market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 39 Purification services market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 40 RNA market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 41 Custom oligo synthesis services market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 42 25 nmol market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 43 100 nmol market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 44 1000 nmol market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 45 10000 nmol market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 46 Modification services market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 47 Purification services market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 48 U.S. oligonucleotide synthesis market: Application movement analysis
• Fig. 49 U.S. oligonucleotide synthesis market: Application outlook and key takeaways
• Fig. 50 PCR primers market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 51 PCR assays & panels market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 52 Sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 53 DNA microarrays market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 54 Fluorescence in situ hybridization (FISH) market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 55 Antisense oligonucleotides market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 56 Other applications market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 57 U.S. oligonucleotide synthesis market End-use outlook key takeaways
• Fig. 58 U.S. oligonucleotide synthesis market: End-use movement analysis
• Fig. 59 Academic research institutes market estimates and forecast, 2018 - 2030 (USD Million))
• Fig. 60 Diagnostic laboratories market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 61 Pharmaceutical & biotechnology companies market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 62 Key company categorization
• Fig. 63 Company market positioning
• Fig. 64 Market participant categorization
• Fig. 65 Strategy framework